RADIOIMMUNOTHERAPY OF COLORECTAL-CANCER IN MINIMAL RESIDUAL DISEASE AND IN AN ADJUVANT SETTING - EVALUATION OF I-131-LABELED AND Y-90-LABELED IGG AND FRAGMENTS VERSUS STANDARD CHEMOTHERAPY IN A NUDE-MOUSE MODEL
Tm. Behr et al., RADIOIMMUNOTHERAPY OF COLORECTAL-CANCER IN MINIMAL RESIDUAL DISEASE AND IN AN ADJUVANT SETTING - EVALUATION OF I-131-LABELED AND Y-90-LABELED IGG AND FRAGMENTS VERSUS STANDARD CHEMOTHERAPY IN A NUDE-MOUSE MODEL, The Journal of nuclear medicine, 38(5), 1997, pp. 14-14